A citation-based method for searching scientific literature

Carmen Dominguez-Brauer, Kelsie L Thu, Jacqueline M Mason, Heiko Blaser, Mark R Bray, Tak W Mak. Mol Cell 2015
Times Cited: 230







List of co-cited articles
606 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
14

Cell cycle proteins as promising targets in cancer therapy.
Tobias Otto, Piotr Sicinski. Nat Rev Cancer 2017
696
9

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
9


Polo-like kinase 4 inhibition produces polyploidy and apoptotic death of lung cancers.
Masanori Kawakami, Lisa Maria Mustachio, Lin Zheng, Yulong Chen, Jaime Rodriguez-Canales, Barbara Mino, Jonathan M Kurie, Jason Roszik, Pamela Andrea Villalobos, Kelsie L Thu,[...]. Proc Natl Acad Sci U S A 2018
43
16

Microtubule-binding agents: a dynamic field of cancer therapeutics.
Charles Dumontet, Mary Ann Jordan. Nat Rev Drug Discov 2010
7


How Taxol/paclitaxel kills cancer cells.
Beth A Weaver. Mol Biol Cell 2014
460
7

Cell cycle, CDKs and cancer: a changing paradigm.
Marcos Malumbres, Mariano Barbacid. Nat Rev Cancer 2009
7

Functional characterization of CFI-400945, a Polo-like kinase 4 inhibitor, as a potential anticancer agent.
Jacqueline M Mason, Dan Chi-Chia Lin, Xin Wei, Yi Che, Yi Yao, Reza Kiarash, David W Cescon, Graham C Fletcher, Donald E Awrey, Mark R Bray,[...]. Cancer Cell 2014
107
6

Mechanisms of chromosomal instability.
Sarah L Thompson, Samuel F Bakhoum, Duane A Compton. Curr Biol 2010
323
6

Lethality to human cancer cells through massive chromosome loss by inhibition of the mitotic checkpoint.
Geert J P L Kops, Daniel R Foltz, Don W Cleveland. Proc Natl Acad Sci U S A 2004
321
6

Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics.
Rosie Elizabeth Ann Gutteridge, Mary Ann Ndiaye, Xiaoqi Liu, Nihal Ahmad. Mol Cancer Ther 2016
163
6


Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.
Jianjiong Gao, Bülent Arman Aksoy, Ugur Dogrusoz, Gideon Dresdner, Benjamin Gross, S Onur Sumer, Yichao Sun, Anders Jacobsen, Rileen Sinha, Erik Larsson,[...]. Sci Signal 2013
6

On the road to cancer: aneuploidy and the mitotic checkpoint.
Geert J P L Kops, Beth A A Weaver, Don W Cleveland. Nat Rev Cancer 2005
832
5

The spindle-assembly checkpoint in space and time.
Andrea Musacchio, Edward D Salmon. Nat Rev Mol Cell Biol 2007
5

The spindle assembly checkpoint.
Pablo Lara-Gonzalez, Frederick G Westhorpe, Stephen S Taylor. Curr Biol 2012
467
5


Characterization of novel MPS1 inhibitors with preclinical anticancer activity.
M Jemaà, L Galluzzi, O Kepp, L Senovilla, M Brands, U Boemer, M Koppitz, P Lienau, S Prechtl, V Schulze,[...]. Cell Death Differ 2013
71
7

Dissecting the role of MPS1 in chromosome biorientation and the spindle checkpoint through the small molecule inhibitor reversine.
Stefano Santaguida, Anthony Tighe, Anna Morena D'Alise, Stephen S Taylor, Andrea Musacchio. J Cell Biol 2010
327
5

Pharmacologic inhibition of the anaphase-promoting complex induces a spindle checkpoint-dependent mitotic arrest in the absence of spindle damage.
Xing Zeng, Frederic Sigoillot, Shantanu Gaur, Sungwoon Choi, Kathleen L Pfaff, Dong-Chan Oh, Nathaniel Hathaway, Nevena Dimova, Gregory D Cuny, Randall W King. Cancer Cell 2010
219
5

BI 6727, a Polo-like kinase inhibitor with improved pharmacokinetic profile and broad antitumor activity.
Dorothea Rudolph, Martin Steegmaier, Matthias Hoffmann, Matthias Grauert, Anke Baum, Jens Quant, Christian Haslinger, Pilar Garin-Chesa, Günther R Adolf. Clin Cancer Res 2009
269
5

Evidence that mitotic exit is a better cancer therapeutic target than spindle assembly.
Hsiao-Chun Huang, Jue Shi, James D Orth, Timothy J Mitchison. Cancer Cell 2009
228
5

Microtubules as a target for anticancer drugs.
Mary Ann Jordan, Leslie Wilson. Nat Rev Cancer 2004
5

The hallmarks of cancer.
D Hanahan, R A Weinberg. Cell 2000
5

Molecular Regulation of the Spindle Assembly Checkpoint by Kinases and Phosphatases.
G Manic, F Corradi, A Sistigu, S Siteni, I Vitale. Int Rev Cell Mol Biol 2017
28
17

The cell cycle and cancer.
Gareth H Williams, Kai Stoeber. J Pathol 2012
300
5

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.
Aravind Subramanian, Pablo Tamayo, Vamsi K Mootha, Sayan Mukherjee, Benjamin L Ebert, Michael A Gillette, Amanda Paulovich, Scott L Pomeroy, Todd R Golub, Eric S Lander,[...]. Proc Natl Acad Sci U S A 2005
5

Targeting mitosis exit: A brake for cancer cell proliferation.
Xinran Liu, Yuchen Chen, Yangkai Li, Robert B Petersen, Kun Huang. Biochim Biophys Acta Rev Cancer 2019
19
26

Leader of the SAC: molecular mechanisms of Mps1/TTK regulation in mitosis.
Spyridon T Pachis, Geert J P L Kops. Open Biol 2018
39
12

Mitotic catastrophe: a mechanism for avoiding genomic instability.
Ilio Vitale, Lorenzo Galluzzi, Maria Castedo, Guido Kroemer. Nat Rev Mol Cell Biol 2011
489
5

Cytokinesis defects and cancer.
Susanne M A Lens, René H Medema. Nat Rev Cancer 2019
73
6


Elevating the frequency of chromosome mis-segregation as a strategy to kill tumor cells.
Aniek Janssen, Geert J P L Kops, René H Medema. Proc Natl Acad Sci U S A 2009
214
4

Inhibition of the spindle assembly checkpoint kinase TTK enhances the efficacy of docetaxel in a triple-negative breast cancer model.
A R R Maia, J de Man, U Boon, A Janssen, J-Y Song, M Omerzu, J G Sterrenburg, M B W Prinsen, N Willemsen-Seegers, J A D M de Roos,[...]. Ann Oncol 2015
64
6

Effects of aneuploidy on cellular physiology and cell division in haploid yeast.
Eduardo M Torres, Tanya Sokolsky, Cheryl M Tucker, Leon Y Chan, Monica Boselli, Maitreya J Dunham, Angelika Amon. Science 2007
578
4

SAK/PLK4 is required for centriole duplication and flagella development.
M Bettencourt-Dias, A Rodrigues-Martins, L Carpenter, M Riparbelli, L Lehmann, M K Gatt, N Carmo, F Balloux, G Callaini, D M Glover. Curr Biol 2005
407
4

Cell biology. Reversible centriole depletion with an inhibitor of Polo-like kinase 4.
Yao Liang Wong, John V Anzola, Robert L Davis, Michelle Yoon, Amir Motamedi, Ashley Kroll, Chanmee P Seo, Judy E Hsia, Sun K Kim, Jennifer W Mitchell,[...]. Science 2015
224
4

Mechanisms to suppress multipolar divisions in cancer cells with extra centrosomes.
Mijung Kwon, Susana A Godinho, Namrata S Chandhok, Neil J Ganem, Ammar Azioune, Manuel Thery, David Pellman. Genes Dev 2008
417
4

A mechanism linking extra centrosomes to chromosomal instability.
Neil J Ganem, Susana A Godinho, David Pellman. Nature 2009
913
4

The discovery of Polo-like kinase 4 inhibitors: design and optimization of spiro[cyclopropane-1,3'[3H]indol]-2'(1'H).ones as orally bioavailable antitumor agents.
Peter B Sampson, Yong Liu, Narendra Kumar Patel, Miklos Feher, Bryan Forrest, Sze-Wan Li, Louise Edwards, Radoslaw Laufer, Yunhui Lang, Fuqiang Ban,[...]. J Med Chem 2015
66
6

The MPS1 family of protein kinases.
Xuedong Liu, Mark Winey. Annu Rev Biochem 2012
126
4

Dinaciclib Induces Anaphase Catastrophe in Lung Cancer Cells via Inhibition of Cyclin-Dependent Kinases 1 and 2.
Alexey V Danilov, Shanhu Hu, Bernardo Orr, Kristina Godek, Lisa Maria Mustachio, David Sekula, Xi Liu, Masanori Kawakami, Faye M Johnson, Duane A Compton,[...]. Mol Cancer Ther 2016
24
16

High levels of the Mps1 checkpoint protein are protective of aneuploidy in breast cancer cells.
Jewel Daniel, Jonathan Coulter, Ju-Hyung Woo, Kathleen Wilsbach, Edward Gabrielson. Proc Natl Acad Sci U S A 2011
95
4

Functional characterization of CFI-402257, a potent and selective Mps1/TTK kinase inhibitor, for the treatment of cancer.
Jacqueline M Mason, Xin Wei, Graham C Fletcher, Reza Kiarash, Richard Brokx, Richard Hodgson, Irina Beletskaya, Mark R Bray, Tak W Mak. Proc Natl Acad Sci U S A 2017
43
9

Small molecule targeting the Hec1/Nek2 mitotic pathway suppresses tumor cell growth in culture and in animal.
Guikai Wu, Xiao-Long Qiu, Longen Zhou, Jiewen Zhu, Richard Chamberlin, Johnson Lau, Phang-Lang Chen, Wen-Hwa Lee. Cancer Res 2008
73
5

Targeting Polo-like kinase in cancer therapy.
Yan Degenhardt, Thomas Lampkin. Clin Cancer Res 2010
184
4

Synergistic blockade of mitotic exit by two chemical inhibitors of the APC/C.
Katharine L Sackton, Nevena Dimova, Xing Zeng, Wei Tian, Mengmeng Zhang, Timothy B Sackton, Johnathan Meaders, Kathleen L Pfaff, Frederic Sigoillot, Hongtao Yu,[...]. Nature 2014
146
4

Targeting mitotic exit with hyperthermia or APC/C inhibition to increase paclitaxel efficacy.
Serena Giovinazzi, Dhruv Bellapu, Viacheslav M Morozov, Alexander M Ishov. Cell Cycle 2013
33
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.